Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

Cognitive Therapy

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Beck's Cognitive Therapy

Beck's Cognitive Therapy

Cognitive therapy is a psychological approach designed to address distortions in thinking, which can lead to negative emotions and unrealistic beliefs. These cognitive distortions often influence how individuals interpret and respond to situations, exacerbating emotional distress. Below are some prevalent cognitive distortions, their characteristics, and examples of how they manifest in thought processes.
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring Group Differences in Attenuated Symptoms and Functioning Between Clinical High-Risk Individuals With and Without Posttraumatic Stress Disorder.

Early intervention in psychiatry·2026

Same author

Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts.

Nature. Mental health·2026

Same author

Tobacco Use is Related to Parietal-Hippocampal Connectivity in People at Clinical High Risk for Psychosis.

medRxiv : the preprint server for health sciences·2026

Same author

Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI Canada.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2026

Same author

Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Same author

Correlation networks of blood proteins in the neuroimmunology of schizophrenia-replication and extension.

Translational psychiatry·2026

Search research articles

Related Experiment Video

Updated: May 14, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Cognitive remediation in schizophrenia.

Yoshio Kaneko¹, Matcheri Keshavan

¹Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA. ; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA. ; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology

|February 23, 2013

Summary

Cognitive deficits are core to schizophrenia and impact daily functioning. Cognitive remediation programs, focusing on neuroplasticity principles, show effectiveness in improving cognitive function for schizophrenia patients.

Keywords:

Cognition disorders/pathology Cognition disorders/rehabilitation Cognition disorders/therapy Neuronal plasticity Schizophrenia

More Related Videos

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

Related Experiment Videos

Last Updated: May 14, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

Area of Science:

Neuroscience
Psychiatry
Cognitive Psychology

Background:

Cognitive deficits are a primary feature of schizophrenia, significantly impacting daily functioning.
Current treatments for schizophrenia are insufficient in addressing these cognitive impairments.
Neuroplasticity alterations are implicated in cognitive deficits, suggesting potential for remediation.

Purpose of the Study:

To review the role of neuroplasticity in schizophrenia-related cognitive deficits.
To outline key principles for designing effective cognitive remediation interventions.
To discuss existing cognitive remediation programs and future research directions.

Main Methods:

Review of literature on cognitive deficits in schizophrenia and neuroplasticity.
Analysis of principles guiding the design of cognitive remediation programs.
Discussion of specific programs like Cognitive Enhancement Therapy (CET).

Main Results:

Cognitive remediation, guided by principles of intensity, duration, and tailored progression, can improve cognitive function.
Programs like CET have demonstrated effectiveness in enhancing neurocognitive and social cognitive skills in schizophrenia.
Preserved neuroplasticity offers a target for cognitive remediation strategies.

Conclusions:

Cognitive remediation is a promising approach for addressing core cognitive deficits in schizophrenia.
Future research should explore pharmacologic synergy, non-invasive stimulation, and psychosocial interventions.
Improving access to cognitive remediation in clinical settings is crucial for patient outcomes.